Article Text

Download PDFPDF
Highlights from the literature

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Antidepressants in pregnancy

Up to 8% of pregnant women are prescribed antidepressants, and there is understandable concern about whether these drugs have any adverse neurodevelopmental effects on the child. Some earlier cohort studies have suggested that there might be, but it is difficult to separate the effects of the drugs from the depression itself. A study from Australia is therefore reassuring (Acta Paeds on-line July 2013): they compared 35 infants exposed to antidepressants during the 2nd and 3rd trimesters with 23 unmedicated controls. The medications were mostly selective serotonin reuptake inhibitors (SSRIs) and most were taken for the whole pregnancy. The children were all assessed using the Bayley scales (BSID-III) by blinded assessors at 18 months. There were no significant differences in any of the domains. One note of caution: the study was part-sponsored by pharmaceutical company Pfizer. As paediatricians we frequently see the results of untreated maternal depression on the child as neglect and abuse: this, and some other studies, should reassure pregnant women that it is best to continue to take prescribed antidepressants.

Antifungals in pregnancy

Some case reports have highlighted a possible association between long-term use of antifungal drugs such as Fluconazole, and specific birth defects, leading the Food and Drugs Administration …

View Full Text